Nadia Dawn Ali, MD

Hematology
Accepting new patients
Sees patients age 18 and up
Penn Blood Disorders Center
Make an appointmentCall 215-615-6555
Headshot of Nadia Dawn Ali, MD
Penn Medicine Provider

About me

  • Director, Sickle Cell Program
  • Associate Professor of Clinical Medicine (Hematology-Oncology)

My education and training

  • Medical School: Southern Illinois University
  • Fellowship: Robert Wood Johnson University Hospital

Spoken languages

English
English

Insurance accepted

Please contact the practice and/or the member services department of your insurance company for specific details before receiving services. Providers may participate in some, but not all, products offered by a health plan; providers may also accept plans at some practice locations but not others.

Locations

Penn Medicine hospital privileges

  • Hospital of the University of Pennsylvania: Has privileges to treat patients in the hospital.
Dr. Ali is a Penn Medicine physician.

Qualifications and experience

Treatments and Conditions

Research

Publications

Ewy J, Senapati S, Ali ND, Gracia CR. Special considerations in assisted reproductive technology for patients with hematologic disease. , Fertil Steril., 124(2): 2025,200-211

Braun E, McVay K, Koelper N, Ali N, Gollomp K, Roe AH Induced and spontaneous abortion outcomes among individuals with sickle cell disease. Contraception. , Contraception, 111052: 2025

Jian Jeff Fu, Anjali Seth, Nadia Ali, Ashwin Chandar, Ashish Bains. ALK-positive Large B-Cell Lymphoma With Multiple Epithelial Antigen Expression and PABPC1::ALK Fusion : A Novel Molecular Alteration , Am J Surg Pathol , 47(8): 2023,950-954

Stack A, Black S, Gupta B, Zhao H, Ali N. Correlation between the 4T Score, Enzyme-Linked Immunosorbent Assay and Serotonin Release Assay for Diagnosis of Heparin Induced Thrombocytopenia. , American Society of Hematology Annual Meeting, New Orleans, LA.: 2022

Yousef I, Desai PB, Sehgal S, Gupta R, Gordon M, Weir M, Ali N, Criner GJ, Rao AK, Rali P. Thromboelastography (TEG) in COVID-19 Patients - Not All Hypercoagulable. , American Thoracic Society International Conference, Virtual Meeting.: 2021

Berardi, GG; Rosario Vega, JA; Ali, N. Can you Spot the Schistocytes? Pernicious Anemia with Severe B12 Deficiency Presenting as Hemolytic Anemia. , Society of Hospital Medicine Conference, Philadelphia, PA.: 2021

Rali P, O’Corragain O, Oresanya L, Yu D, Sheriff O, Weiss R, Myers C, Desai P, Ali N, Stack A, Bromberg M, Lubitz A, Panaro J, Bashir R, Lakhter V, Caricchio R, Gupta R, Dass C, Maruti K, Lu X, Rao AK, Cohen G, Criner G, Choi E. Incidence of venous thromboembolism in coronavirus disease 2019: An experience from a single large academic center , J Vasc Surg Venous Lymphat Disord , 9(3): 2021,585-591

Stack A, Ali N, Khan N. Breast Implant-associated Anaplastic Large Cell Lymphoma: A Review with Emphasis on the Role of Brentuximab Vedotin. , J Cell Immunol, 2(3): 2020,80-89

Ali ND and Bains A. Triple hit B-cell lymphoma with diffuse kidney involvement sparing the glomeruli. , Blood , 134(10): 2019,842. doi: 10.1182/blood.2019001752.

Ali ND, Donohue K, Zandieh S, Chen C, Moore D, Poplin E, Shah MM, Nosher J, Gui B, Jabbour SK, Spencer K, Carpizo DR. Conditional Survival Analysis of Metastatic Colorectal Cancer Patients Living 24 Months: A Single Institutional Study. , Am J Clin Oncol , 42(6): 2019,512-518